Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

GSK - GSK Plc - ADR

Close
43.91
0.170   0.387%

Share volume: 3,129,062
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%
$43.74
0.17
0.39%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
54%
Profitability 63%
Dept financing 49%
Liquidity 51%
Performance 48%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.00%
1 Month
11.45%
3 Months
0.69%
6 Months
5.55%
1 Year
28.42%
2 Year
43.82%
Key data
Stock price
$43.91
P/E Ratio 
14.50
DAY RANGE
$43.53 - $43.98
EPS 
$3.05
52 WEEK RANGE
$32.44 - $45.37
52 WEEK CHANGE
$0.30
MARKET CAP 
91.005 B
YIELD 
3.44%
SHARES OUTSTANDING 
2.073 B
DIVIDEND
$0.3857
EX-DIVIDEND DATE
08/16/2024
NEXT EARNINGS DATE
10/30/2024
BETA 
0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,021,150
AVERAGE 30 VOLUME 
$3,834,367
Company detail
CEO: Emma Walmsley
Region: US
Website: https://www.gsk.com/
Employees: 69,400
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England.

Recent news